Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$97.75 - $129.67 $0 - $0
0 New
0 $0
Q2 2024

Aug 14, 2024

SELL
$85.28 - $112.6 $18.4 Million - $24.2 Million
-215,181 Closed
0 $0
Q1 2024

May 13, 2024

BUY
$59.21 - $92.9 $743,026 - $1.17 Million
12,549 Added 6.19%
215,181 $19.7 Million
Q4 2023

Feb 09, 2024

SELL
$37.55 - $62.64 $312,866 - $521,916
-8,332 Reduced 3.95%
202,632 $12.7 Million
Q3 2023

Nov 03, 2023

BUY
$43.4 - $62.52 $640,063 - $922,044
14,748 Added 7.52%
210,964 $9.34 Million
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $764,814 - $896,074
-16,245 Reduced 7.65%
196,216 $9.55 Million
Q1 2023

May 11, 2023

BUY
$36.57 - $58.29 $7.77 Million - $12.4 Million
212,461 New
212,461 $11.8 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $0 - $0
0 New
0 $0
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $0 - $0
0 New
0 $0
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $0 - $0
0 New
0 $0
Q2 2022

Aug 12, 2022

BUY
$28.13 - $44.54 $0 - $0
0 New
0 $0
Q1 2022

May 13, 2022

BUY
$30.32 - $91.33 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022

BUY
$86.26 - $119.0 $0 - $0
0 New
0 $0
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021

BUY
$86.05 - $119.72 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021

BUY
$66.66 - $111.74 $0 - $0
0 New
0 $0

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.